Analysis Meghmani Organics Limited (MOL)
6/4/2024
Analysis of Meghmani Organics Limited (MOL)
Meghmani Organics Limited (MOL) is showing some interesting indicators based on the provided data:1. **Price Movement**: The closing prices for MOL have been relatively stable around 2800-2820 in the recent days, with some fluctuations in the highs and lows.
2. **RSI Indicator**: The Relative Strength Index (RSI) values are around 51-52, indicating a neutral stance in terms of overbought or oversold conditions.
3. **MACD Indicator**: The Moving Average Convergence Divergence (MACD) values have shown some variability, with both positive and negative values. The MACD histogram has been fluctuating, suggesting some indecision in the momentum.
4. **Moving Averages**: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values are close to each other, indicating a convergence of trends.
Overall, the stock seems to be in a consolidation phase with no clear trend direction. Traders and investors may need to wait for clearer signals before making significant trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results before that, ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, the results for the quarter ending on August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has a beta of 1.264 and has shown a slight increase in the fifty-two week range.
Valuation metrics show a high PEG ratio and forward PE ratio, with a relatively high price to book and price to sales ratios. The company's market capitalization and enterprise value are substantial.
The stock price summary includes moving averages, fifty-two week high and low prices, and the percentage change in the fifty-two week range.
Lastly, dividends and splits information shows the company's dividend dates, split history, and dividend yield metrics. The company has a consistent dividend payout and yield.
Income statement 💸
These are the revenues. Draw conclusions.Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and the next two fiscal years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates increases to 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the analysts are forecasting moderate to healthy sales growth for both the upcoming quarters and the next fiscal year, with an increasing number of analysts providing estimates for the company's performance.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. The current year growth rate is estimated to be 7.6%.
2. The next quarter growth rate is expected to be 5.1%.
3. The current quarter growth rate is also projected to be 5.1%.
4. The next year growth rate is forecasted to be 9.7%.
5. The average annual growth rate for the next 5 years is estimated to be 9.7%.
6. The average annual growth rate for the past 5 years was 20.1%.
These estimates suggest that the company is expected to experience steady growth in the upcoming periods, with a slightly higher growth rate projected for the next year compared to the current year. Additionally, the past 5 years have seen a significantly higher growth rate compared to the future estimates, indicating a potential slowdown in growth.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to finance its operations over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics.
MACD of MOL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
